Studies have found that ALI development is closely correlated to the activation of NF-κB signaling, and inhibiting the NF-κB pathway is found to effectively alleviate the symptoms of ALI [33, 34]. The gene discussed is NFKB1; the disease is acute respiratory distress syndrome.